Ezetimibe Reverse Cholesterol Transport (RCT) Pilot Study

NCT00701727 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

31

Enrollment

OTHER

Sponsor class

Conditions

Hypercholesterolemia

Interventions

DRUG: ezetimibe
DRUG: Placebo

Sponsor

Radiant Research